1. Home
  2. DWSN vs ICCC Comparison

DWSN vs ICCC Comparison

Compare DWSN & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$2.23

Market Cap

79.5M

Sector

Energy

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

SELL

Current Price

$10.75

Market Cap

93.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DWSN
ICCC
Founded
1952
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.5M
93.1M
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
DWSN
ICCC
Price
$2.23
$10.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 88.8K
10.0K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
★ 7.73%
N/A
EPS Growth
53.85
53.85
EPS
0.14
★ 0.41
Revenue
★ $145,773,000.00
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $16.00
$25.76
Revenue Growth
N/A
★ 51.64
52 Week Low
$1.50
$4.52
52 Week High
$7.85
$12.10

Technical Indicators

Market Signals
Indicator
DWSN
ICCC
Relative Strength Index (RSI) 27.39 63.42
Support Level $2.03 $9.42
Resistance Level $2.39 $10.75
Average True Range (ATR) 0.22 0.24
MACD -0.02 0.12
Stochastic Oscillator 8.64 89.13

Price Performance

Historical Comparison
DWSN
ICCC

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: